JUN 15, 2019 3:41 PM PDT

Understanding and Treating the Mechanisms That Drive Rheumatoid Arthritis

WRITTEN BY: Carmen Leitch

The immune system has to be able to differentiate between our own cells and cells that are invading our body; when it cannot, diseases like rheumatoid arthritis (RA) arise. In RA, immune system cells mistakenly attack the joints and cause the painful inflammation that is a hallmark of the disease, which affects around 1.3 million people. Now scientists are learning more about the biological mechanisms that drive RA. These findings have been reported in Nature Immunology and Science translational Medicine, and can be used to develop new therapeutics.

"Right now, the standard approach for treating patients is a trial and error approach. We try the first-line of medication for three months and if it does not work, we try the next one," noted co-senior study author Laura Donlin, Ph.D., who is Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery (HSS) and is featured inthe video. "Sometimes it can take a year or more to find an effective treatment. Meanwhile, the disease progresses to the extent of irreversible damage in some of the cases."

A variety of cell types are involved in RA, but in these new studies, the researchers identified subsets of these cell types that are found in RA patients and can help show why some don’t respond to therapeutics. In the Nature Immunology report, joint fluid from 36 RA patients and a control group of osteoarthritis (which does not involve the immune system) patients were analyzed. There were eighteen unique cell types found in the RA patient group. One of those subsets is a type of fibroblast, found at levels that were fifteen times higher in RA patients than controls, which release a molecule that promotes inflammation -  interleukin-6.

"Cutting-edge single-cell RNA sequencing technology allowed us to see the complexity of the cell populations in RA tissue for the first time," explained Dr. Donlin. "However, determining whether these expanded cell populations are a cause or an effect of the disease, will require further research." RNA sequencing enables researchers to get a snapshot of all the genes that are active in a single cell at one time and is a way to characterize individual cells.

In the Science Translational Medicine report, the investigators identified a subset of immune cells called macrophages in RA patients; the subset was termed HBEGF+ inflammatory macrophages. Other studies have shown that macrophages are involved in RA, and they release another molecule that drives RA inflammation called tumor necrosis factor (TNF).

Image credit: Pixabay

The researchers asked whether a common arthritis medication, COX inhibitors that are a type of nonsteroidal anti-inflammatory drug (NSAID), impacted these macrophages. They determined that NSAIDs can impact those macrophages, but don’t affect TNF.

"This finding may explain why NSAIDs treat pain but are not disease-modifying in RA," said Dr. Donlin. "A better approach may be to use NSAIDs in combination with anti-TNF medications to shut down both inflammatory pathways."

A drug that was created as an experimental cancer treatment was able to disrupt HBEGF+ inflammatory macrophage activity. It’s probably not a good candidate for use in patients, but can offer insight into how to engineer a good drug.

"Our experiment demonstrated that it is possible to target activity of these cells, but this drug has significant systemic side effects in people," said Dr. Donlin. "Our work sets the stage for developing better drugs in the future that could target the same mechanism but in a more specific fashion."


Sources: AAAS/Eurekalert! via Hospital for Special Surgery, Nature Immunology, Science Translational Medicine

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 29, 2022
Genetics & Genomics
Catching an RNA Switch in Action
MAR 29, 2022
Catching an RNA Switch in Action
Cells have to express the right genes to carry out the essential functions of life. When genes are expressed, they are t ...
APR 14, 2022
Neuroscience
Immune B Cells Undergo Significant Changes in Postpartum Depression
APR 14, 2022
Immune B Cells Undergo Significant Changes in Postpartum Depression
Immune cells known as B cells undergo significant changes in women with postpartum depression (PPD). The corresponding s ...
APR 20, 2022
Cell & Molecular Biology
Nutrigenomics - Understanding how Genes Affect Nutrient Tolerance
APR 20, 2022
Nutrigenomics - Understanding how Genes Affect Nutrient Tolerance
There are some things most organisms need to survive, like protein, fat, or sugars. But dietary requirements can vary wi ...
MAY 05, 2022
Microbiology
Electricity Can Have a Surprising Effect on Biofilms
MAY 05, 2022
Electricity Can Have a Surprising Effect on Biofilms
Bacteria can exist as individual cells, but there is strength in numbers. Many microbes form clusters called biofilms, l ...
MAY 17, 2022
Cell & Molecular Biology
Single-Cell Atlas Reveals Gene Activity Across Human Tissues
MAY 17, 2022
Single-Cell Atlas Reveals Gene Activity Across Human Tissues
Scientists have learned a lot about individual genes, especially those that are connected to human disease. And while we ...
MAY 23, 2022
Coronavirus
The Genetics Underlying Susceptibility to Severe COVID-19
MAY 23, 2022
The Genetics Underlying Susceptibility to Severe COVID-19
Since the onset of the pandemic, researchers and clinicians have been trying to determine why COVID-19 is more severe in ...
Loading Comments...